Mrs. Prades-Ogorelkova is joining the UK-based company - FindMeCure Ltd., at an essential moment of the company related to the launch of their new big data platform identifying country-specific challenges and patient recruitment alternatives when planning a clinical trial.
Miroslava Prades-Ogorelkova has a PhD from Leopold-Franzens-Universität Innsbruck and did an executive Business & Management program from Science and Technology at IE Business School. She started her professional career in the research environment first in Canada at the Biotechnology Research Institute and later in Spain at the Center of Genomic Regulation, as a Marie Sklodowska-Curie fellow.
Miroslava realised her passion is within the Biotech and clinical research space and she moved to the Pharma sector. During the past 12 years she has worked for startups and companies like Leo Pharma, Quintiles (IQVIA) and TFS CRO. Her passion for innovation and accelerating new technologies led her to join the EC Independent Experts board and EIT Health as a reviewer of applied research projects and new startup companies, evaluating their progress, and potential. She recently joined one of the leading innovators on the skincare market - ISDIN, as a Clinical Trial Manager.
Mrs. Prades-Ogorelkova is joining the UK-based company - FindMeCure Ltd., at an essential moment of the company related to the launch of their new big data platform identifying country-specific challenges and patient recruitment alternatives when planning a clinical trial. Since the beginning of the year, the company has been working with its clients to take advantage of modern algorithms and AI innovations to automate manual data analyses for strategic clinical trial feasibility assessments. FindMeCure is currently providing its new technology to CROs, biotech, and pharma companies looking to make their feasibility and patient recruitment planning processes scalable but also with the patient in mind. Their approach not only eliminates feasibility manual research, but also provides the patient perspective by providing information about clinical trial awareness, the patient pathway, patient communities landspace and other lay patients' insights.
“We bring thousands of reliable data sources, analyze them and ensure that our industry customers make the best choices where and how to run the clinical trial so that they can engage with the most interested patients.” - says Maya Zlatanova, the CEO of FindMeCure, industry speaker and author of articles about patient engagement.
As a part of FindMeCure Ltd., Mrs. Prades-Ogorelkova will be supporting the product development team by guiding them through the everyday’s feasibility and clinical trial challenges and creating new technological solutions to solve them. She and the team are both determined to work towards a smarter way to predict and manage patient recruitment in order to empower the new generation of clinical trials like decentralised and virtual clinical trials.
For more detail, visit: https://www.findmecure.com/